Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with Tixagevimab plus Cilgavimab in vaccinated patients with autoimmune disease

C. M. Connolly, A. H. Karaba, T. Po Yu Chiang, M. Teles, J. D. Kim, T. Scott Johnson, J. L. Alejo, D. L. Segev, L. Christopher-Stine, W. A. Werbel, J. J. Paik

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1202-1203
Number of pages2
JournalClinical and experimental rheumatology
Volume41
Issue number5
DOIs
StatePublished - May 2023

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this